51
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%

&
Pages 525-531 | Published online: 29 Mar 2012

References

  • KassMAHeuerDKHigginbothamEJThe Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary openangle glaucomaArch Ophthalmol200212070171312049574
  • KassMAGordonMOGaoFDelaying treatment of ocular hypertension: the ocular hypertension treatment studyArch Ophthalmol201012827628720212196
  • Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol19981264985059780094
  • HeijlALeskeMCBengtssonBReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
  • Collaborative Normal-Tension Glaucoma Study GroupComparison of glaucomatous progression between untreated patients with normaltension glaucoma and patients with therapeutically reduced intraocular pressuresAm J Ophthalmol19981264874979780093
  • AsraniSZeimerRWilenskyJLarge diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucomaJ Glaucoma2000913414210782622
  • LeePPWaltJWRosenblattLCAssociation between intraocular pressure variation and glaucoma progression: data from a United States chart reviewAm J Ophthalmol200714490190717919446
  • CaprioliJColemanALIntraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention studyOphthalmology200811511231129e318082889
  • Nouri-MahdaviKHoffmanDColemanALPredictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention StudyOphthalmology20041111627163515350314
  • MuschDCGillespieBWNiziolLMIntraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment StudyOphthalmology20111181766177321600658
  • BengtssonBLeskeMCHymanLHeijlAFluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trialOphthalmology200711420520917097736
  • BengtssonBHeijlADiurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertensionGraefes Arch Clin Exp Ophthalmol200524351351815756577
  • LiuJHZhangXKripkeDFWeinrebRNTwenty-four-hour intraocular pressure pattern associated with early glaucomatous changesInvest Ophthalmol Vis Sci2003441586159012657596
  • LiuJHBoulignyRPKripkeDFWeinrebRNNocturnal elevation of intraocular pressure is detectable in the sitting positionInvest Ophthalmol Vis Sci2003444439444214507890
  • LiuJHKripkeDFTwaMDTwenty-four-hour pattern of intraocular pressure in the aging populationInvest Ophthalmol Vis Sci1999402912291710549652
  • LiuJHSitAJWeinrebRNVariation of 24-hour intraocular pressure in healthy individuals: right eye versus left eyeOphthalmology20051121670167516095707
  • MosaedSLiuJHWeinrebRNCorrelation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patientsAm J Ophthalmol200513932032415733994
  • RealiniTWeinrebNWisniewskiSShort-term repeatability of diurnal intraocular pressure patterns in glaucomatous individualsOphthalmology2011118475120709404
  • RealiniTWeinrebRNWisniewskiSRDiurnal intraocular pressure patterns are not repeatable in the short term in healthy individualsOphthalmology20101171700170420557945
  • RealiniTBarberLBurtonDFrequency of asymmetric intraocular pressure fluctuations among patients with and without glaucomaOphthalmology20021091367137112093664
  • SitAJLiuJHWeinrebRNAsymmetry of right versus left intraocular pressures over 24 hours in glaucoma patientsOphthalmology200611342543016406537
  • BhoradeAMGordonMOWilsonBVariability of intraocular pressure measurements in observation participants in the ocular hypertension treatment studyOphthalmology200911671772419243824
  • BarnebeyHSOrengo-NaniaSFlowersBEThe safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solutionAm J Ophthalmol20051401715990081
  • FellmanRLSullivanEKRatliffMComparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trialOphthalmology2002109998100811986110
  • GandolfiSParedesTGoldbergIComparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucomaEur J Ophthalmol201222344422167541
  • GoldbergICunha-VazJJakobsenJEComparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertensionJ Glaucoma20011041442211711841
  • GrossRLPeaceJHSmithSEDuration of IOP reduction with travoprost BAK-free solutionJ Glaucoma20081721722218414108
  • LewisRAKatzGJWeissMJTravoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacyJ Glaucoma2007169810317224758
  • NetlandPALandryTSullivanEKTravoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol200113247248411589866
  • CaprioliJVarmaRIntraocular pressure: modulation as treatment for glaucomaAm J Ophthalmol2011152340344e221855671
  • De MoraesCGHillVTelloCLower corneal hysteresis is associated with more rapid glaucomatous visual field progressionJ Glaucoma6212011 [Epub ahead of print.]
  • LichterPRMuschDCGillespieBWInterim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgeryOphthalmology20011081943195311713061